Drug Discovery World

AUGUST 9, 2024

The news highlights this week all centre around significant US Food and Drug Administration (FDA) regulatory decisions, including new approvals for drugs for solid tumours, hepatitis B and glioma. The post This week in drug discovery (5-9 August) appeared first on Drug Discovery World (DDW).

FDA 130

FDA FDA Approval Engineering Drugs 130

Drug Discovery World

NOVEMBER 29, 2023

Researchers have created a mathematical model that can accurately depict Alzheimer’s disease progression in individual patients, paving the way for personalised treatment and faster development of therapies.

Drug Development 130

Drug Development Pharmaceutical Companies Drugs FDA Approval 130

Advarra

AUGUST 16, 2022

Orphan drugs have historically faced a number of barriers, such as limited research and development (R&D) investment due to an expected lack of profitability as well as challenges in clinical trial design and recruitment. Before 1983, only 38 orphan drugs had received U.S. Food and Drug Administration (FDA) approval.

Disease 52

Disease Clinical Trials FDA Approval FDA 52

Drug Discovery World

JANUARY 17, 2024

This, coupled with a growing understanding of the heterogeneity of cancer as the basis for treatment resistance, tumour evolution and therefore the main source of therapeutic failure, 6 has highlighted the importance of developing personalised therapy. Tumour heterogeneity and resistance to cancer therapies. Cancer 19 , 553–567 (2019).

DNA 147

DNA Clinical Trials RNA Treatment 147